<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The case reported here was that of an old woman characterized by <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>, chromosome clonal abnormality, fluctuation of the percent of blast cells at 20%, and negative evidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in whole-body 2-[F18] fluoro-2-deoxy-d-<z:chebi fb="105" ids="17234">glucose</z:chebi> <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (F18-FDG PET) </plain></SENT>
<SENT sid="1" pm="."><plain>After about 10 months, the blast cells accounted for about 25%, the <z:mp ids='MP_0000002'>morphology</z:mp> of which was similar to that of previous ones, and F18-FDG PET demonstrated diffusing increased uptake in the right upper leg and lymph nodes and patchy high uptake of bone marrow </plain></SENT>
<SENT sid="2" pm="."><plain>2-[F18]-fluoro-2-<z:chebi fb="0" ids="15866">deoxyglucose</z:chebi> can reflect extramedullary infiltration and bone marrow cellularity of the whole body, compared with invasive, regional biopsies and <z:hpo ids='HP_0002835'>aspirations</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The value of 2-[F18]-fluoro-2-<z:chebi fb="0" ids="15866">deoxyglucose</z:chebi> or 3'-deoxy-3'-[F18]-fluorothymidine <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography as an indicator in predicting the transformation of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> needs to be explored in the future </plain></SENT>
</text></document>